Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-07-24FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C. The approval updates BARACLUDE's l…
-
CLINICAL_TRIALS trial_result · 2007-06-28Clinical Trial Update: ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency [NA]
This trial update notes a completed study (NCT00493506) evaluating ProAlgaZyme algae infusion for immunodeficiency, with HIV infection and H…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection [Phase 4]
Phase 4 trial results report virological and clinical efficacy of tenofovir disoproxil fumarate and emtricitabine in HIV/HBV co-infected pat…
-
CLINICAL_TRIALS trial_result · 2007-04-20Clinical Trial Update: Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients [Phase 4]
A Phase 4 trial assessing the efficacy of a combined Hepatitis A and Hepatitis B vaccine to prevent Hepatitis B in patients undergoing hemod…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination [Phase 1]
A Phase 1 pilot safety study evaluated whether the Protector Cap Jet Injector can prevent cross-contamination. The trial status is completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-27FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Baraclude (entecavir) filed by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2007-03-27FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) from E.R. Squibb & Sons, L.L.C. The action updates or expands the prod…
-
CLINICAL_TRIALS research · 2007-03-21Clinical Trial Update: Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Clinical trial update examining whether polymorphisms in the IL-1 gene complex influence the development of chronic hepatitis B and hepatoce…
-
CLINICAL_TRIALS trial_result · 2007-03-08Clinical Trial Update: Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. [NA]
This document reports that the continued access study of Adefovir Dipivoxil for chronic hepatitis B has been terminated.
-
EMA safety_alert · 2007-03-05Public statement: Baraclude (entecavir): Occurrence of a resistant HIV variant in a patient co-infected with HIV and HBV
EMA public statement about the occurrence of a resistant HIV variant in a patient co-infected with HIV and hepatitis B while on Baraclude (e…
-
FDA label_change · 2007-02-23FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Baraclude (entecavir) filed by E.R. Squibb & Sons, L.L.C., related to labeling changes.
-
FDA approval · 2007-02-23FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) filed by E.R. Squibb & Sons, L.L.C.; details of the supplemental approval …
-
CLINICAL_TRIALS trial_result · 2007-02-13Clinical Trial Update: HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection [Phase 2]
Phase 2 trial of HepeX-B for end-stage liver disease due to hepatitis B infection in post-transplant patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]
Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulat…
-
CLINICAL_TRIALS trial_result · 2006-10-30Clinical Trial Update: Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) [Phase 4]
This clinical trial update describes a Phase 4 study of lamivudine in HBeAg-negative chronic hepatitis B patients in Asia and confirms the s…
-
CLINICAL_TRIALS trial_result · 2006-10-03Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]
Phase 3 trial comparing an adjuvanted hepatitis B vaccine to a double dose Engerix-B in adults on pre-dialysis or haemodialysis; the study s…
-
CLINICAL_TRIALS trial_result · 2006-09-26Clinical Trial Update: A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B [Phase 4]
This clinical trial update reports the completion of a Phase 4 randomized controlled trial evaluating lamivudine for acute hepatitis B. The …
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV [Phase 2]
A Phase 2 clinical trial evaluating 4-Methylumbelliferone as a treatment for chronic hepatitis B and chronic hepatitis C is ongoing, with cu…
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: KRN7000 in Chronic Hepatitis B [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 trial of KRN7000 (alpha-galactosylceramide) in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2006-08-07Clinical Trial Update: Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
This trial update reports on the long-term effects of pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C, incl…
-
FDA approval · 2006-06-13FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. Lamivudine is used to treat HIV-1 infe…
-
CLINICAL_TRIALS trial_result · 2006-05-25Clinical Trial Update: Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta [Phase 4]
A Phase 4 clinical trial evaluating the combination of pegylated interferon alfa-2b and ribavirin for chronic hepatitis B and hepatitis D.
-
EMA safety_alert · 2006-05-08European Medicines Agency finds no signal for decreased effectiveness of HBVAXPRO and Procomvax
The EMA reports no evidence of decreased effectiveness for the hepatitis B vaccines HBVAXPRO and Procomvax following investigations.